Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Endocrinol Metab Clin North Am. 2021 Mar;50(1):11–23. doi: 10.1016/j.ecl.2020.10.002

Figure 1: Comparing Components of Different Diagnostic Criteria.

Figure 1:

NIH PCOS must include both HA+OD, +/− PCOM. There are no endocrine or metabolic differences between phenotypes A and B; there is no need to assess PCOM in NIH PCOS. Rotterdam Criteria requires at least 2 out of the 3 criteria to be present, adding 2 new phenotypes HA+PCOM and OD+PCOM. The prevalence of PCOS increases from ~7% to 15% when including the two non-NIH Rotterdam phenotypes.